Call Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Tree in-bud sign golden s sign
1. Dr Mazen Qusaibaty
MD, DIS
Head Pulmonary and Internist
Department
Ibnalnafisse Hospital
Ministry of Syrian health
Email: Qusaibaty@gmail.com
1. Tree-in-bud sign
2. Golden S sign
26. Quiz / Tree-in-bud sign
This sign could be
seen in :
A. HRCT scanner of
thorax
B. CT scanner of
thorax
C. PA chest x ray
D. Left profile chest x
ray
27. Tree-in-bud sign
This sign could be
seen in :
A. HRCT scanner of
thorax
B. CT scanner of
thorax
C. PA chest x ray
D. Left profile chest x
ray
28. Tree-in-bud sign could be seen
• In:
A. Endobronchial
Tuberculosis
B. Asthma
C. Bronchoalveolar
carcinoma
28
29. Tree-in-bud sign could be seen
• In:
A. Endobronchial
Tuberculosis
B. Asthma
C. Bronchoalveolar
carcinoma
29
30. Case 1
• A 29-year-old man
• Acute myeloid leukemia after bone marrow
transplantation
• The patient had a history of fever and cough
30
32. Case 1
• Multiple, small,
centrolobular
nodules of soft-
tissue attenuation
connected to linear
branching opacities
(arrows)
• Tree-in-bud sign
32
33. Case 1
At serologic examination, an infection with
A. Klebsiella
pneumoniae
B. Mycoplasma
pneumoniae
C. Streptococcus
pneumoniae
33
34. Case 1
At serologic examination, an infection with
A. Klebsiella
pneumoniae
B. Mycoplasma
pneumoniae
C. Streptococcus
pneumoniae
34
35. Tree-in-bud sign associated with
bronchiolar infection
• Transverse thin-
section CT scan
through right lower
lobe in a patient with
airways disease and
bacterial infection
related to AIDS
(acquired immunodeficiency
syndrome)
35
36. Tree-in-bud sign associated with
bronchiolar infection
• Multiple impacted
centrilobular
bronchioles result in
tree-in-bud
appearance
(arrowheads).
• Bronchiectasis is also
present
36
37. Lung slice from patient with
bronchopneumonia
• Impacted mucus-
and pus-filled
bronchioles
(arrows) are visible
throughout the
lung
37
43. Golden S sign
The upper curve of
the reverse S
(concave infero-laterally)
44. Golden S sign
A central mass causing
the collapse forming
the lower curve
(convex infero-medially)
45. • When a lobe collapses around a large central mass,
the peripheral lung collapses and the central portion
of lung is prevented from collapsing by the presence
of the mass.
45
46. • The relevant fissure is concave toward the lung
peripherally but convex centrally, and the shape
of the fissure resembles an S or a reverse S .
46
47. Conclusion
• Golden S sign - indicates lobar collapse with a
central mass, suggesting an obstructing
bronchogenic carcinoma in an adult
47
Editor's Notes
A Pictorial Review of “Signs in Thoracic Imaging”Karuppasamy, K.1, Abhyankar-Gupta, M.1, Fewins, H.1, Curtis, J.21The Cardiothoracic Centre - Liverpool NHS Trust, 2Aintree University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
Dead Space The portion of each breath that does not participate in gas exchange. Anatomic dead space is the volume of the conducting airways; physiologic dead space also include sthe contribution of alveoli that are well-ventilated but poorly perfused.
Dead Space
Dead space is the portion of each tidal volume that does not take part in gas exchange.
There are two different ways to define dead space-- anatomic and physiologic. Anatomic dead space is the total volume of the conducting airways from the nose or mouth down to the level of the terminal bronchioles, and is about 150 ml on the average in humans. The anatomic dead space fills with inspired air at the end of each inspiration, but this air is exhaled unchanged. Thus, assuming a normal tidal volume of 500 ml, about 30% of this air is "wasted" in the sense that it does not participate in gas exchange.
Physiologic dead space includes all the non-respiratory parts of the bronchial tree included in anatomic dead space, but also factors in alveoli which are well-ventilated but poorly perfused and are therefore less efficient at exchanging gas with the blood. Because atmospheric PCO2 is practically zero, all the CO2 expiredin a breath can be assumed to come from the communicating alveoli and none from the dead space. By measuring the PCO2 in the communicating alveoli (which is the same as that in the arterial blood) and the PCO2 in the expired air, one can use the Bohr Equation to compute the "diluting," non-CO2 containing volume, the physiologic dead space.
In healthy individuals, the anatomic and physiologic dead spaces are roughly equivalent, since all areas of the lung are well perfused. However, in disease states where portions of the lung are poorly perfused, the physiologic dead space may be considerably larger than the anatomic dead space. Hence, physiologic dead space is a more clinically useful concept than is anatomic dead space.
Dead Space The portion of each breath that does not participate in gas exchange. Anatomic dead space is the volume of the conducting airways; physiologic dead space also include sthe contribution of alveoli that are well-ventilated but poorly perfused.
Dead Space
Dead space is the portion of each tidal volume that does not take part in gas exchange.
There are two different ways to define dead space-- anatomic and physiologic. Anatomic dead space is the total volume of the conducting airways from the nose or mouth down to the level of the terminal bronchioles, and is about 150 ml on the average in humans. The anatomic dead space fills with inspired air at the end of each inspiration, but this air is exhaled unchanged. Thus, assuming a normal tidal volume of 500 ml, about 30% of this air is "wasted" in the sense that it does not participate in gas exchange.
Physiologic dead space includes all the non-respiratory parts of the bronchial tree included in anatomic dead space, but also factors in alveoli which are well-ventilated but poorly perfused and are therefore less efficient at exchanging gas with the blood. Because atmospheric PCO2 is practically zero, all the CO2 expiredin a breath can be assumed to come from the communicating alveoli and none from the dead space. By measuring the PCO2 in the communicating alveoli (which is the same as that in the arterial blood) and the PCO2 in the expired air, one can use the Bohr Equation to compute the "diluting," non-CO2 containing volume, the physiologic dead space.
In healthy individuals, the anatomic and physiologic dead spaces are roughly equivalent, since all areas of the lung are well perfused. However, in disease states where portions of the lung are poorly perfused, the physiologic dead space may be considerably larger than the anatomic dead space. Hence, physiologic dead space is a more clinically useful concept than is anatomic dead space.
Dead Space The portion of each breath that does not participate in gas exchange. Anatomic dead space is the volume of the conducting airways; physiologic dead space also include sthe contribution of alveoli that are well-ventilated but poorly perfused.
Dead Space
Dead space is the portion of each tidal volume that does not take part in gas exchange.
There are two different ways to define dead space-- anatomic and physiologic. Anatomic dead space is the total volume of the conducting airways from the nose or mouth down to the level of the terminal bronchioles, and is about 150 ml on the average in humans. The anatomic dead space fills with inspired air at the end of each inspiration, but this air is exhaled unchanged. Thus, assuming a normal tidal volume of 500 ml, about 30% of this air is "wasted" in the sense that it does not participate in gas exchange.
Physiologic dead space includes all the non-respiratory parts of the bronchial tree included in anatomic dead space, but also factors in alveoli which are well-ventilated but poorly perfused and are therefore less efficient at exchanging gas with the blood. Because atmospheric PCO2 is practically zero, all the CO2 expiredin a breath can be assumed to come from the communicating alveoli and none from the dead space. By measuring the PCO2 in the communicating alveoli (which is the same as that in the arterial blood) and the PCO2 in the expired air, one can use the Bohr Equation to compute the "diluting," non-CO2 containing volume, the physiologic dead space.
In healthy individuals, the anatomic and physiologic dead spaces are roughly equivalent, since all areas of the lung are well perfused. However, in disease states where portions of the lung are poorly perfused, the physiologic dead space may be considerably larger than the anatomic dead space. Hence, physiologic dead space is a more clinically useful concept than is anatomic dead space.
Dead Space The portion of each breath that does not participate in gas exchange. Anatomic dead space is the volume of the conducting airways; physiologic dead space also include sthe contribution of alveoli that are well-ventilated but poorly perfused.
Dead Space
Dead space is the portion of each tidal volume that does not take part in gas exchange.
There are two different ways to define dead space-- anatomic and physiologic. Anatomic dead space is the total volume of the conducting airways from the nose or mouth down to the level of the terminal bronchioles, and is about 150 ml on the average in humans. The anatomic dead space fills with inspired air at the end of each inspiration, but this air is exhaled unchanged. Thus, assuming a normal tidal volume of 500 ml, about 30% of this air is "wasted" in the sense that it does not participate in gas exchange.
Physiologic dead space includes all the non-respiratory parts of the bronchial tree included in anatomic dead space, but also factors in alveoli which are well-ventilated but poorly perfused and are therefore less efficient at exchanging gas with the blood. Because atmospheric PCO2 is practically zero, all the CO2 expiredin a breath can be assumed to come from the communicating alveoli and none from the dead space. By measuring the PCO2 in the communicating alveoli (which is the same as that in the arterial blood) and the PCO2 in the expired air, one can use the Bohr Equation to compute the "diluting," non-CO2 containing volume, the physiologic dead space.
In healthy individuals, the anatomic and physiologic dead spaces are roughly equivalent, since all areas of the lung are well perfused. However, in disease states where portions of the lung are poorly perfused, the physiologic dead space may be considerably larger than the anatomic dead space. Hence, physiologic dead space is a more clinically useful concept than is anatomic dead space.
Dead Space The portion of each breath that does not participate in gas exchange. Anatomic dead space is the volume of the conducting airways; physiologic dead space also include sthe contribution of alveoli that are well-ventilated but poorly perfused.
Dead Space
Dead space is the portion of each tidal volume that does not take part in gas exchange.
There are two different ways to define dead space-- anatomic and physiologic. Anatomic dead space is the total volume of the conducting airways from the nose or mouth down to the level of the terminal bronchioles, and is about 150 ml on the average in humans. The anatomic dead space fills with inspired air at the end of each inspiration, but this air is exhaled unchanged. Thus, assuming a normal tidal volume of 500 ml, about 30% of this air is "wasted" in the sense that it does not participate in gas exchange.
Physiologic dead space includes all the non-respiratory parts of the bronchial tree included in anatomic dead space, but also factors in alveoli which are well-ventilated but poorly perfused and are therefore less efficient at exchanging gas with the blood. Because atmospheric PCO2 is practically zero, all the CO2 expiredin a breath can be assumed to come from the communicating alveoli and none from the dead space. By measuring the PCO2 in the communicating alveoli (which is the same as that in the arterial blood) and the PCO2 in the expired air, one can use the Bohr Equation to compute the "diluting," non-CO2 containing volume, the physiologic dead space.
In healthy individuals, the anatomic and physiologic dead spaces are roughly equivalent, since all areas of the lung are well perfused. However, in disease states where portions of the lung are poorly perfused, the physiologic dead space may be considerably larger than the anatomic dead space. Hence, physiologic dead space is a more clinically useful concept than is anatomic dead space.
San Jose Three-Dimensional Perspective Satellite Image, Photo, Costa Rica 2000
Normal airways. Axial (a), coronal (b), and sagittal (c)volume-rendered images demonstrate normal central and peripheral airways. Note the sheet overlying the chest wall.
CT scans allow doctors to see cross-sectional images (slices) of your body. This slice shows heart and lung tissue.
Normal airways. Axial (a), coronal (b), and sagittal (c)volume-rendered images demonstrate normal central and peripheral airways. Note the sheet overlying the chest wall.
Normal airways. Axial (a), coronal (b), and sagittal (c)volume-rendered images demonstrate normal central and peripheral airways. Note the sheet overlying the chest wall.
Refers to the pattern of opacity seen in a HRCT; the terminal tufts of TIB represent inflammatory material filling respiratory bronchioles and alveolar ducts and the stalks of TIB represent filling within terminal bronchiole; e.g. Endobronchial TB
Refers to the pattern of opacity seen in a HRCT; the terminal tufts of TIB represent inflammatory material filling respiratory bronchioles and alveolar ducts and the stalks of TIB represent filling within terminal bronchiole; e.g. Endobronchial TB
Inflammatory material filling : TB/RB/AD
Refers to the pattern of opacity seen in a HRCT; the terminal tufts of TIB represent inflammatory material filling respiratory bronchioles and alveolar ducts and the stalks of TIB represent filling within terminal bronchiole; e.g. Endobronchial TB
Refers to the pattern of opacity seen in a HRCT; the terminal tufts of TIB represent inflammatory material filling respiratory bronchioles and alveolar ducts and the stalks of TIB represent filling within terminal bronchiole; e.g. Endobronchial TB
Thin-section CT scan obtained in a 29-year-old man with acute myeloid leukemia after bone marrow transplantation. The patient had a history of fever and cough. Image shows multiple, small, centrilobular nodules of soft-tissue attenuation connected to linear branching opacities (arrows). Note the morphologic similarities to the photograph of the tree in bud (Fig 1). At serologic examination, an infection with Mycoplasma pneumoniae was confirmed.
Thin-section CT scan obtained in a 29-year-old man with acute myeloid leukemia after bone marrow transplantation. The patient had a history of fever and cough. Image shows multiple, small, centrilobular nodules of soft-tissue attenuation connected to linear branching opacities (arrows). Note the morphologic similarities to the photograph of the tree in bud (Fig 1). At serologic examination, an infection with Mycoplasma pneumoniae was confirmed.
Thin-section CT scan obtained in a 29-year-old man with acute myeloid leukemia after bone marrow transplantation. The patient had a history of fever and cough. Image shows multiple, small, centrilobular nodules of soft-tissue attenuation connected to linear branching opacities (arrows). Note the morphologic similarities to the photograph of the tree in bud (Fig 1). At serologic examination, an infection with Mycoplasma pneumoniae was confirmed.
Thin-section CT scan obtained in a 29-year-old man with acute myeloid leukemia after bone marrow transplantation. The patient had a history of fever and cough. Image shows multiple, small, centrilobular nodules of soft-tissue attenuation connected to linear branching opacities (arrows). Note the morphologic similarities to the photograph of the tree in bud (Fig 1). At serologic examination, an infection with Mycoplasma pneumoniae was confirmed.
Thin-section CT scan obtained in a 29-year-old man with acute myeloid leukemia after bone marrow transplantation. The patient had a history of fever and cough. Image shows multiple, small, centrilobular nodules of soft-tissue attenuation connected to linear branching opacities (arrows). Note the morphologic similarities to the photograph of the tree in bud (Fig 1). At serologic examination, an infection with Mycoplasma pneumoniae was confirmed.
Tree-in-bud sign associated with bronchiolar infection. (a) Transverse thin-section CT scan through right lower lobe in a patient with airways disease and bacterial infection related to acquired immunodeficiency syndrome. Multiple impacted centrilobular bronchioles result in tree-in-bud appearance (arrowheads). Bronchiectasis is also present. (b) Lung slice from patient with bronchopneumonia. Impacted mucus- and pus-filled bronchioles (arrows) are visible throughout the lung; this is the pathologic examination equivalent of the tree-in-bud sign. (Image courtesy of Martha Warnock, MD, University of California, San Francisco.)
Tree-in-bud sign associated with bronchiolar infection. Transverse thin-section CT scan through right lower lobe in a patient with airways disease and bacterial infection related to acquired immunodeficiency syndrome. Multiple impacted centrilobular bronchioles result in tree-in-bud appearance (arrowheads). Bronchiectasis is also present. Lung slice from patient with bronchopneumonia. Impacted mucus- and pus-filled bronchioles (arrows) are visible throughout the lung; this is the pathologic examination equivalent of the tree-in-bud sign. (Image courtesy of Martha Warnock, MD, University of California, San Francisco.)
Tree-in-bud sign associated with bronchiolar infection. Transverse thin-section CT scan through right lower lobe in a patient with airways disease and bacterial infection related to acquired immunodeficiency syndrome. Multiple impacted centrilobular bronchioles result in tree-in-bud appearance (arrowheads). Bronchiectasis is also present. Lung slice from patient with bronchopneumonia. Impacted mucus- and pus-filled bronchioles (arrows) are visible throughout the lung; this is the pathologic examination equivalent of the tree-in-bud sign. (Image courtesy of Martha Warnock, MD, University of California, San Francisco.)
Refers to a reverse S shaped shadow caused by right upper lobe collapse forming the upper curve of the reverse S (concave infero-laterally) and a central mass causing the collapse forming the lower curve (convex infero-medially)
Refers to a reverse S shaped shadow caused by right upper lobe collapse forming the upper curve of the reverse S (concave infero-laterally) and a central mass causing the collapse forming the lower curve (convex infero-medially)
Refers to a reverse S shaped shadow caused by right upper lobe collapse forming the upper curve of the reverse S (concave infero-laterally) and a central mass causing the collapse forming the lower curve (convex infero-medially)
Refers to a reverse S shaped shadow caused by right upper lobe collapse forming the upper curve of the reverse S (concave infero-laterally) and a central mass causing the collapse forming the lower curve (convex infero-medially)
When a lobe collapses around a large central mass, the peripheral lung collapses and the central portion of lung is prevented from collapsing by the presence of the mass.
The relevant fissure is concave toward the lung peripherally but convex centrally, and the shape of the fissure resembles an S or a reverse S .
When a lobe collapses around a large central mass, the peripheral lung collapses and the central portion of lung is prevented from collapsing by the presence of the mass.
The relevant fissure is concave toward the lung peripherally but convex centrally, and the shape of the fissure resembles an S or a reverse S .